MetaADEDB 2.0 @ LMMD
Ethchlorvynol
(ZEHYJZXQEQOSON-AATRIKPKSA-N)
Structure
SMILES
CCC(C#C)(/C=C/Cl)O
Type(s)
Approved; Illicit; Withdrawn
ATC code(s)
N05CM08
Molecular Formula:
C7H9ClO
Molecular Weight:
144.599
Log P:
1.5132
Hydrogen Bond Acceptor:
1
Hydrogen Bond Donor:
1
TPSA:
20.23
CAS Number(s):
113-18-8
Synonym(s)
1.
Ethchlorvynol
2.
Ethchlorovynol
3.
Ethchlorvinol
4.
Placidyl
External Link(s)
MeSHD004984
PubChem Compound5281077
ChEBI4882
CHEMBLCHEMBL591
DrugBankDB00189
IUPHAR/BPS Guide to PHARMACOLOGY7180
KEGGcpd:C07833
dr:D00704
Therapeutic Target DatabaseD03VZH
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1DementiaFAERS: 1US FAERS
2AgitationCanada Vigilance: 3Canada Vigilance
3Amblyopia5352221CTD
4AnxietyCanada Vigilance: 1Canada Vigilance
5AsthmaCanada Vigilance: 1Canada Vigilance
6AtaxiaCanada Vigilance: 1Canada Vigilance
7Cardiac ArrestCanada Vigilance: 1Canada Vigilance
8Completed SuicideCanada Vigilance: 5Canada Vigilance
9DeliriumCanada Vigilance: 1Canada Vigilance
10Depressed Level of ConsciousnessCanada Vigilance: 1Canada Vigilance
11DiplopiaCanada Vigilance: 1Canada Vigilance
12DisorientationCanada Vigilance: 1Canada Vigilance
13Drug DependenceCanada Vigilance: 1Canada Vigilance
14DysarthriaCanada Vigilance: 1Canada Vigilance
15DysgeusiaCanada Vigilance: 1Canada Vigilance
16DysphoniaCanada Vigilance: 1Canada Vigilance
17HeadacheCanada Vigilance: 1Canada Vigilance
18Hemianopsia6226702CTD
19HyperkinesiaCanada Vigilance: 1Canada Vigilance
20HyperreflexiaCanada Vigilance: 1Canada Vigilance
21HyperventilationCanada Vigilance: 1Canada Vigilance
22HypotensionCanada Vigilance: 1Canada Vigilance
23NauseaCanada Vigilance: 3Canada Vigilance
24NystagmusCanada Vigilance: 1Canada Vigilance
25Optic Neuritis6226702CTD
26OverdoseCanada Vigilance: 3Canada Vigilance
27Peripheral Nervous System Diseases5352221CTD
28PetechiaeCanada Vigilance: 2Canada Vigilance
29PruritusCanada Vigilance: 2Canada Vigilance
30Somnambulism453369CTD
31SomnolenceCanada Vigilance: 2Canada Vigilance
32Substance Withdrawal Syndrome7352588CTD
33Suicide attemptCanada Vigilance: 1Canada Vigilance
34TachycardiaCanada Vigilance: 1Canada Vigilance
35Urinary Retention3783765CTD
36UrticariaCanada Vigilance: 2Canada Vigilance
37VomitingCanada Vigilance: 2Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120141

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.